CI Global Health Sciences Corporate Class

Series F USD
 

Fund overview

This fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Fund details

description of elementelement value
Inception date August 2000
CAD Total net assets ($CAD)
As at 2025-12-31
$154.4 million
NAVPS
As at 2026-02-04
$27.9623
MER (%)
As at 2025-09-30
1.24
Management fee (%) 0.90
Asset class Sector Equity
Currency USD
Minimum investment $500 initial/$25 additional
Distribution frequency Quarterly
Last distribution $0.5033

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

F 324
A ISC 301
DSC SO* 401
LL SO 1401
P 90324
*No new purchases directly into switch only funds.

Performance2 As at 2026-01-31

Growth of $10,000 (Since inception date)

growth of 10k graph

Calendar year performance

annual performance graph

average annual compound returns

YTD 1 Mo 3 Mo 6 Mo 1 Y 3 Y 5 Y 10 Y Inception*
-0.10% -0.10% 6.92% 18.48% 2.67% 3.39% 0.45% 3.97% 7.11%
*Since inception date

Distribution history3

Payable date Total
2022-03-25 0.5033
2021-03-26 0.1714
2020-12-18 0.2724
2020-09-25 0.2584
2020-06-26 0.1886
Payable date Total
2020-03-20 0.4395
2019-12-13 0.2744
2019-09-27 0.3063
2019-06-21 0.2883
2019-03-22 0.4530

Management team

First we'll display the Team Company and then the Team members
Greg Quickmire
Peter Hofstra

CI Global Health Sciences Corporate Class

Series F USD
 
Portfolio allocations4 As at 2025-12-31
Asset allocation (%)
  • US Equity 82.27
  • International Equity 16.79
  • Cash and Equivalents 0.94
Sector allocation (%)
  • Healthcare 95.98
  • Exchange Traded Fund 3.08
  • Cash and Cash Equivalent 0.94
Geographic allocation(%)
  • United States 82.31
  • United Kingdom 9.37
  • Switzerland 6.66
  • Canada 0.86
  • Netherlands 0.80
Top holdings5
Sector (%)
1. Eli Lilly and Co Drugs 14.23%
2. AstraZeneca PLC Drugs 9.37%
3. DexCom Inc Healthcare Equipment 7.88%
4. Thermo Fisher Scientific Inc Healthcare Equipment 6.91%
5. Danaher Corp Healthcare Equipment 6.88%
6. Johnson & Johnson Drugs 5.94%
7. Boston Scientific Corp Healthcare Equipment 4.94%
8. UnitedHealth Group Inc Healthcare Services 4.93%
9. IQVIA Holdings Inc Drugs 4.92%
10. Intuitive Surgical Inc Healthcare Equipment 4.90%
11. Vertex Pharmaceuticals Inc Drugs 4.08%
12. AbbVie Inc Drugs 3.98%
13. Stryker Corp Healthcare Equipment 3.69%
14. Roche Holding AG - Partcptn Drugs 3.38%
15. Merck & Co Inc Drugs 3.14%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.